{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:57:40Z","timestamp":1784170660338,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Italian Ministry for University and Research","doi-asserted-by":"crossref","award":["2009YJTBAZ"],"award-info":[{"award-number":["2009YJTBAZ"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.mce.2016.02.005","type":"journal-article","created":{"date-parts":[[2016,2,10]],"date-time":"2016-02-10T04:17:34Z","timestamp":1455077854000},"page":"61-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Expression of Peroxisome Proliferator-Activated Receptor alpha (PPAR\u03b1) in somatotropinomas: Relationship with Aryl hydrocarbon receptor Interacting Protein (AIP) and in\u00a0vitro effects of fenofibrate in GH3 cells"],"prefix":"10.1016","volume":"426","author":[{"given":"Sandra","family":"Rotondi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Modarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Antonietta","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliya","family":"Rostomyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Sanita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian F.","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Angelucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonietta","family":"Arcella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Giangaspero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Beckers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5916-8997","authenticated-orcid":false,"given":"Marie-Lise","family":"Jaffrain-Rea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2016.02.005_bib1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2165\/00003495-199754040-00007","article-title":"Micronised fenofibrate: a review of its pharmacodynamic properties and clinical efficacy in the management of dyslipidaemia","volume":"54","author":"Adkins","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.mce.2016.02.005_bib2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1530\/eje.0.1510173","article-title":"Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease","volume":"151","author":"Ambrosi","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.mce.2016.02.005_bib3","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1177\/002215540104901210","article-title":"Control of autofluorescence of archival formaldehyde-fixed, paraffin-embedded tissue in confocal laser scanning microscopy (CLSM)","volume":"49","author":"Baschong","year":"2001","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1016\/j.mce.2016.02.005_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000106830","article-title":"The PPAR-gamma activator rosiglitazone fails to lower plasma growth hormone and insulin-like growth factor-1 levels in patients with acromegaly","volume":"86","author":"Bastemir","year":"2007","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.mce.2016.02.005_bib5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1210\/er.2012-1013","article-title":"Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene","volume":"34","author":"Beckers","year":"2013","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.mce.2016.02.005_bib6","doi-asserted-by":"crossref","first-page":"36407","DOI":"10.1074\/jbc.M004236200","article-title":"Binding of aryl hydrocarbon receptor (AhR) to AhR-interacting protein","volume":"275","author":"Bell","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2016.02.005_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tem.2009.12.003","article-title":"Pituitary somatostatin receptor signaling","volume":"21","author":"Ben-Shlomo","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.mce.2016.02.005_bib8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11060-014-1385-6","article-title":"Characterization of fenofibrate-mediated anti-proliferative pro-apoptotic effects on high-grade gliomas and anti-invasive effects on glioma stem cells","volume":"117","author":"Binello","year":"2014","journal-title":"J.\u00a0Neurooncol"},{"key":"10.1016\/j.mce.2016.02.005_bib9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.bbrc.2004.05.035","article-title":"Different ways to regulate the PPARalpha stability","volume":"319","author":"Blanquart","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mce.2016.02.005_bib10","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1530\/eje.0.1500863","article-title":"PPARgamma inhibits GH synthesis and secretion and increases apoptosis of pituitary GH-secreting adenomas","volume":"150","author":"Bogazzi","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.mce.2016.02.005_bib11","doi-asserted-by":"crossref","first-page":"E1411","DOI":"10.1210\/jc.2012-1111","article-title":"Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway","volume":"97","author":"Chahal","year":"2012","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2016.02.005_bib13","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1210\/jc.2006-2513","article-title":"Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families","volume":"92","author":"Daly","year":"2007","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2016.02.005_bib14","doi-asserted-by":"crossref","first-page":"e0117107","DOI":"10.1371\/journal.pone.0117107","article-title":"Regulation of aryl hydrocarbon receptor interacting protein (AIP) protein expression by MiR-34a in sporadic somatotropinomas","volume":"10","author":"D\u00e9nes","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.mce.2016.02.005_bib15","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1530\/ERC-13-0043","article-title":"AIP regulates cAMP signalling and GH secretion in GH3 cells","volume":"20","author":"Formosa","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.mce.2016.02.005_bib16","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1677\/JOE-07-0020","article-title":"Differential expression of neurogenins and NeuroD1 in human pituitary tumors","volume":"194","author":"Fratticci","year":"2007","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.mce.2016.02.005_bib17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1385\/ENDO:28:2:217","article-title":"Ghrelin reduces voltage-gated potassium currents in GH3 cells via cyclic GMP pathways","volume":"28","author":"Han","year":"2005","journal-title":"Endocrine"},{"key":"10.1016\/j.mce.2016.02.005_bib18","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1172\/JCI200316575","article-title":"PPAR-gamma receptor ligands: novel therapy for pituitary adenomas","volume":"111","author":"Heaney","year":"2003","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.mce.2016.02.005_bib19","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1677\/ERC-09-0094","article-title":"Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications","volume":"16","author":"Jaffrain-Rea","year":"2009","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.mce.2016.02.005_bib20","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1530\/ERC-12-0322","article-title":"Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations","volume":"20","author":"Jaffrain-Rea","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.mce.2016.02.005_bib21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000322787","article-title":"Low aryl hydrocarbon receptor-interacting protein expression is a better marker of invasiveness in somatotropinomas than Ki-67 and p53","volume":"94","author":"Kasuki Jomori de Pinho","year":"2011","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.mce.2016.02.005_bib22","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Endocrine society. Acromegaly: an endocrine society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2016.02.005_bib23","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1007\/s11095-011-0473-y","article-title":"PPAR\u03b1 is regulated by miR-21 and miR-27b in human liver","volume":"28","author":"Kida","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.mce.2016.02.005_bib24","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s12640-010-9166-2","article-title":"Palmitoylethanolamide protects dentate gyrus granule cells via peroxisome proliferator-activated receptor-\u03b1","volume":"19","author":"Koch","year":"2011","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.mce.2016.02.005_bib25","doi-asserted-by":"crossref","first-page":"801609","DOI":"10.1155\/2009\/801609","article-title":"Fasting upregulates PPARalpha target genes in brain and influences pituitary hormone expression in a PPARalpha dependent manner","author":"K\u00f6nig","year":"2009","journal-title":"PPAR Res."},{"key":"10.1016\/j.mce.2016.02.005_bib26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.phrs.2004.07.012","article-title":"An overview on biological mechanisms of PPARs","volume":"51","author":"Kota","year":"2005","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.mce.2016.02.005_bib27","first-page":"430","article-title":"No effect of the PPAR-gamma agonist rosiglitazone on ACTH or cortisol secretion in Nelson's syndrome and Cushing's disease in\u00a0vitro and in\u00a0vivo","volume":"28","author":"Kreutzer","year":"2009","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.mce.2016.02.005_bib28","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1210\/jc.2007-2611","article-title":"The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas","volume":"93","author":"Leontiou","year":"2008","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2016.02.005_bib29","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1471-2407-14-96","article-title":"Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-\u03baB pathway","volume":"14","author":"Li","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.mce.2016.02.005_bib30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/1479-5876-9-176","article-title":"Long-term fenofibrate treatment impaired glucose-stimulated insulin secretion and up-regulated pancreatic NF-kappa B and iNOS expression in monosodium glutamate-induced obese rats: is that a latent disadvantage?","volume":"9","author":"Liu","year":"2011","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.mce.2016.02.005_bib31","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMra062453","article-title":"Acromegaly","volume":"355","author":"Melmed","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.mce.2016.02.005_bib32","doi-asserted-by":"crossref","first-page":"906542","DOI":"10.1155\/2008\/906542","article-title":"PPARalpha ligands as antitumorigenic and antiangiogenic agents","volume":"2008","author":"Pozzi","year":"2008","journal-title":"PPAR Res."},{"key":"10.1016\/j.mce.2016.02.005_bib33","doi-asserted-by":"crossref","first-page":"e002","DOI":"10.1621\/nrs.08002","article-title":"PPARalpha: energy combustion, hypolipidemia, inflammation and cancer","volume":"8","author":"Pyper","year":"2010","journal-title":"Nucl. Recept. Signal"},{"key":"10.1016\/j.mce.2016.02.005_bib34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0300-483X(02)00275-5","article-title":"PPAR alpha and the regulation of cell division and apoptosis","volume":"181\u2013182","author":"Roberts","year":"2002","journal-title":"Toxicology"},{"key":"10.1016\/j.mce.2016.02.005_bib35","first-page":"455","article-title":"Effect of peroxisome proliferator-activated receptor alpha ligand fenofibrate on K(v) channels in the insulin-secreting cell line HIT-T15","volume":"25","author":"Shimomura","year":"2006","journal-title":"Gen. Physiol. Biophys."},{"key":"10.1016\/j.mce.2016.02.005_bib36","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1158\/0008-5472.CAN-13-1928","article-title":"PPAR\u03b1 activation can help prevent and treat non-small cell lung cancer","volume":"74","author":"Skrypnyk","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.mce.2016.02.005_bib37","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ceca.2011.11.003","article-title":"Molecular mechanisms of pituitary endocrine cell calcium handling","volume":"51","author":"Stojilkovic","year":"2012","journal-title":"Cell Calcium"},{"key":"10.1016\/j.mce.2016.02.005_bib38","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1074\/jbc.M211261200","article-title":"Evidence that peroxisome proliferator-activated receptor alpha is complexed with the 90-kDa heat shock protein and the hepatitis virus B X-associated protein 2","volume":"278","author":"Sumanasekera","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2016.02.005_bib39","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1016\/j.febslet.2011.10.021","article-title":"MicroRNA-506 regulates expression of PPAR alpha in hydroxycamptothecin-resistant human colon cancer cells","volume":"58","author":"Tong","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.mce.2016.02.005_bib40","doi-asserted-by":"crossref","first-page":"26652","DOI":"10.1074\/jbc.273.41.26652","article-title":"Activation of the prolactin gene by peroxisome proliferator-activated receptor-alpha appears to be DNA binding-independent","volume":"273","author":"Tol\u00f3n","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.mce.2016.02.005_bib41","doi-asserted-by":"crossref","first-page":"E708","DOI":"10.1152\/ajpendo.00546.2011","article-title":"MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in\u00a0vitro","volume":"303","author":"Trivellin","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2016.02.005_bib42","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/onc.2014.50","article-title":"AIP inactivation leads to pituitary tumorigenesis through defective G\u03b1(i)-cAMP signaling","volume":"34","author":"Tuominen","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2016.02.005_bib43","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1126\/science.1126100","article-title":"Pituitary adenoma predisposition caused by germline mutations in the AIP gene","volume":"312","author":"Vierimaa","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.mce.2016.02.005_bib44","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jsbmb.2012.09.033","article-title":"1,25-Dihydroxyvitamin D3 modulates lipid metabolism in prostate cancer cells through miRNA mediated regulation of PPARA","volume":"136","author":"Wang","year":"2013","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.mce.2016.02.005_bib45","first-page":"137","article-title":"Immunohistochemical detection of PPARgamma receptors in the human pituitary adenomas: correlation with PCNA","volume":"43","author":"Winczyk","year":"2005","journal-title":"Folia Histochem Cytobiol."},{"key":"10.1016\/j.mce.2016.02.005_bib46","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1210\/en.2005-0696","article-title":"Somatostatin increases voltage-gated K+ currents in GH3 cells through activation of multiple somatostatin receptors","volume":"146","author":"Yang","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.mce.2016.02.005_bib47","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ceca.2011.12.005","article-title":"Influence of membrane ion channel in pituitary somatotrophs by hypothalamic regulators","volume":"51","author":"Yang","year":"2012","journal-title":"Cell Calcium"}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720716300326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720716300326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T10:25:02Z","timestamp":1748773502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720716300326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":46,"alternative-id":["S0303720716300326"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2016.02.005","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of Peroxisome Proliferator-Activated Receptor alpha (PPAR\u03b1) in somatotropinomas: Relationship with Aryl hydrocarbon receptor Interacting Protein (AIP) and in\u00a0vitro effects of fenofibrate in GH3 cells","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2016.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}